Davis Asset Management’s Pfizer PFE Stock Holding History

Davis Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107K	Hold	4,428	–	–	﹤0.01%	64
2026 Q1	$124K	Buy	+4,428	New	+$118K	﹤0.01%	57

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Davis Asset Management's PFE Position: Q2 2026 in Review

Davis Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 4,428 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #64.

Davis Asset Management first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. The position peaked at $124K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Davis Asset Management held 4,428 shares of Pfizer worth $107K as of Q2 2026.
Davis Asset Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up ﹤0.01% of Davis Asset Management's portfolio in Q2 2026, its #64 holding.
Davis Asset Management first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
Davis Asset Management's Pfizer position peaked at $124K in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Davis Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.